---
title: Your Monthly Derm Updates Are Ready!
---

Galderma recently announced approval from the Food and Drug Administration (FDA)..

| View in browser JUNE Galderma Announces FDA Approval for Restylane Kysse   Galderma recently announced approval from the Food and Drug Administration (FDA) of their newest hyaluronic acid (HA) filler option, Restylane Kysse. According to the announcement, the "HA filler is the first of its kind to be indicated specifically for lip augmentation and the correction of upper perioral rhytids using XpresHAn Technology, also globally referred to as Optimal Balance Technology (OBT)"       Researchers Identify UV Skin Cancer Trigger   Researchers from the University of Washington School of Medicine in Seattle have identified the 6-4 photoproducts (6-4PPs) as the lesion responsible for DNA damage related to ultraviolet (UV) light exposure, as well as another lesion, cyclobutene pyrimidine dimers (CPDs), which can be attributed to affecting a cell’s reaction to UV.       Trial Demonstrates ‘Real chance to cure’ BRAF-mutant Melanoma   Demonstrated within an analysis completed on the COMBI-AD trial, adjuvant dabrafenib and trametinib provided long-term benefit for patients with resected stage III BRAF V600-mutant melanoma. In a statement to Healio, Axel Hauschild, MD, PhD, professor of dermatology at University Hospital Schleswig-Holstein Campus Kiel in Germany stated: "Even though it met my expectation, to have 50% of patients with high-risk melanoma still without relapse at 5 years is a very good result.”       Dupilumab Approved for Children with Atopic Dermatitis   The U.S. Food and Drug Administration (FDA) has approved dupilumab (Dupixent, Sanofi and Regeneron) for moderate-to-severe atopic dermatitis in children 6 to 11 years whose disease is not well controlled on topical prescription medication. According to a Regeneron press release, this approval marks dupilumab as the only FDA-approved biologic for patients 6-11 years.   3.0 hour activity \| ACCME, ANCC \| Expires May 7, 2021   In an effort to help streamline access and highlight the most valuable and actionable articles, clinical perspectives, and both clinician and patient resources, SBS has launched the new COVID-19 Resource Hub Learn More   View Podcast Library   Read More South Beach Symposium, 1801 N Military Trl Ste 200, Boca Raton, FL 33431-1810, United States, 561-893-8625 Unsubscribe Manage preferences |
| --- |